Live feed
Filing
SC 13G/A
SC 13G/A0000902219-23-000024·Celldex Therapeutics, Inc.
Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Security class unavailable · CUSIP: 15117B202
Event date: 2023-04-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,781,497
- Percent of class
- 10.1200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-23-000024
- Form type
- SC 13G/A
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- May 10, 2023
- Reporting period
- Apr 28, 2023
- Description
- Schedule 13G beneficial ownership